文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

入院降钙素原值及其后续变化与脓毒症预后相关

Combination of Procalcitonin Value on Hospital Admission and Its Subsequent Change in Value Is Associated With the Prognosis of Sepsis.
PubMed 文献 · Crit Care Explor · 2021-01-11
一句话结论脓毒症患者入院PCT<33.2 ng/mL且次日变化<0.0 ng/mL时28天死亡率18.6%,显著高于其他患者。

单中心回顾性观察研究纳入173例≥18岁脓毒症患者,评估入院时降钙素原(PCT)值及其次日变化与28天死亡率的关系。入院PCT中位数14.8 ng/mL,次日变化中位数0 ng/mL,28天死亡率5.8%。单因素分析显示高龄、入院PCT<33.2 ng/mL、PCT变化<0.0 ng/mL与28天死亡率相关;同时满足后两项者死亡率18.6%(8/43),显著高于其他患者。提示入院PCT较低且未下降的脓毒症患者预后较差。

要点

  • 脓毒症患者入院PCT<33.2 ng/mL且次日PCT变化<0.0 ng/mL时,28天死亡率18.6%(8/43),显著高于其他患者(p<0.001)。
  • 单因素分析中,入院PCT<33.2 ng/mL(p=0.007)和PCT变化<0.0 ng/mL( crude OR 5.056,95%CI 1.041-24.545,p=0.046)与28天死亡率相关。
  • 高龄亦与28天死亡率相关( crude OR 5.314,95%CI 1.094-25.806,p=0.044)。
  • 整体队列28天死亡率为5.8%(10/173),入院PCT中位数14.8 ng/mL(IQR 3.5-78.4),次日变化中位数0 ng/mL(IQR -4.5至5.2)。
  • 该研究为单中心回顾性观察,结果需前瞻性验证,不能作为决策阈值直接用于临床。

适用人群与场景

  • 日本单中心重症监护中心,2015年1月1日至2018年3月31日收治的≥18岁脓毒症患者,共173例。

诊断标准与关键阈值

  • 原文未提及脓毒症诊断标准的具体名称和界值。
  • 原文未提及PCT启动或停止治疗的阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 入院PCT<33.2 ng/mL且次日PCT变化<0.0 ng/mL的脓毒症患者28天死亡率较高(18.6%),需警惕预后不良。

研究设计与关键结果

  • 研究类型:单中心、回顾性、观察性研究;样本量173例;无干预。
  • 人群:≥18岁脓毒症患者,中位年龄74岁(IQR 64-79),男性102例。
  • 主要终点:28天死亡率5.8%(10/173)。
  • 单因素分析:高龄crude OR 5.314(95%CI 1.094-25.806,p=0.044);入院PCT<33.2 ng/mL(p=0.007);PCT变化<0.0 ng/mL crude OR 5.056(95%CI 1.041-24.545,p=0.046)与28天死亡率相关。
  • 入院PCT<33.2 ng/mL且PCT变化<0.0 ng/mL者死亡率18.6%(8/43),显著高于其他患者(p<0.001)。
  • 关键次要终点和不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:单中心、回顾性、观察性研究。
  • 证据等级或推荐强度:原文未提及。
  • 局限:单中心、回顾性设计、样本量较小(173例),仅行单因素分析,未提及多因素校正。

对床旁实践的改变

  • 对于脓毒症患者,入院PCT较低(<33.2 ng/mL)且次日未下降(变化<0.0 ng/mL)可能提示预后不良,可考虑加强监测,但该阈值来自单中心回顾性研究,不能作为决策阈值直接推广。
  • 不适用于非脓毒症患者或<18岁人群。
  • 常见陷阱:不能仅凭单次PCT值或变化判断预后,需结合整体临床情况;原文未提供多因素分析结果,关联性不等于因果。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

UNLABELLED: To evaluate the relationship between the procalcitonin value in blood on hospital admission and its subsequent change and prognosis among sepsis patients.

DESIGN: A single-center, retrospective, observational study.

SETTING: Critical care center in Japan.

PATIENTS: Sepsis patients 18 years old or older admitted from January 1, 2015, to March 31, 2018.

INTERVENTIONS: None.

MEASUREMENT AND MAIN RESULTS: Among 173 sepsis patients enrolled, the median age was 74 years old (interquartile range, 64-79 yr old), and there were 102 men. The median value of procalcitonin in blood on hospital admission was 14.8 ng/mL (interquartile range, 3.5-78.4 ng/mL), and the median change in serum procalcitonin value between hospital admission and the next day was 0 ng/mL (interquartile range, -4.5 to 5.2 ng/mL). Mortality at 28 days after hospital admission was 5.8% (10/173). In univariate logistic regression analysis, elderly (crude odds ratio, 5.314; 95% CI, 1.094-25.806; p = 0.044), procalcitonin value of less than 33.2 ng/mL on hospital admission (p = 0.007), and change in serum procalcitonin of less than 0.0 ng/mL (crude odds ratio, 5.056; 95% CI, 1.041-24.545; p = 0.046) were associated with mortality at 28 days after hospital admission. The mortality of patients with a procalcitonin value of less than 33.2 ng/mL on hospital admission and change in serum procalcitonin of less than 0.0 ng/mL was 18.6% (8/43) and was significantly higher than that of other patients (p < 0.001).

CONCLUSIONS: Our study showed the sepsis patients with a procalcitonin value in blood of less than 33.2 ng/mL on hospital admission and change in serum procalcitonin of less than 0.0 ng/mL had high mortality at 28 days after hospital admission.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Muratsu A, Muroya T, Katayama Y, et al. Combination of Procalcitonin Value on Hospital Admission and Its Subsequent Change in Value Is Associated With the Prognosis of Sepsis. Crit Care Explor. 2021. PMID: 33458678. doi:10.1097/CCE.0000000000000298

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。